Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Roberto Carlesi | Researchclopedia

Back to researchers

Roberto Carlesi

Eli Lilly (Italy)

20

Works

3,108

Citations

9

h-index

9

i10-index

Research Topics

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Pancreatic and Hepatic Oncology Research

Affiliations

Roche (United States)1995–1995

Eli Lilly (United States)2020–2020

University of Milan1993–1993

Nuovo Ospedale San Giovanni di Dio1994–1994

Eli Lilly (Italy)2014–2021

Top Works

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

H. Wilke,Kei Muro,et al.

20142,435 citations

Gastrointestinal Tumor Research and Treatment

Lung Cancer Treatments and Mutations

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs,Kohei Shitara,et al.

2019278 citations

RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastroesophageal junction (GEJ) and gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy rainbow IMCL CP12-0922 (I4T-IE-JVBE).

H. Wilke,Eric Van Cutsem,et al.

201492 citations

Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review

Li‐Tzong Chen,Do‐Youn Oh,et al.

201772 citations

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

Juan W. Valle,Arndt Vogel,et al.

202164 citations

Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer

Kei Muro,Sang Cheul Oh,et al.

201540 citations

Effect of Inhaled Furosemide and Torasemide on Bronchial Response to Ultrasonically Nebulized Distilled Water in Asthmatic Subjects

Antonio Foresi,Andrea Pelucchi,et al.

199233 citations

Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study.

Juan W. Valle,Li‐Yuan Bai,et al.

202029 citations

RAINBOW: A global, phase 3, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy: Results of a multiple Cox regression analysis adjusting for prognostic factors.

H. Wilke,Eric Van Cutsem,et al.

201419 citations